Absence of 2′-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS

Molecular Nutrition and Food Research

Volumn 52, Issue 4, 2008, Pages 472-482

  Delatour, Thierry ^a   Mally, Angela ^b   Richoz, Janique ^a   Özden, Sibel ^b   Dekant, Wolfgang ^b   Ihmels, Heiko ^c   Otto, Daniela ^c   Gasparutto, Didier ^d   Marin Kuan, Maricel ^a   Schilter, Benoît ^a   Cavin, Christophe ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF SIEGEN   (Germany)

^d CEA GRENOBLE   (France)

Author keywords

Carcinogenicity; DNA adduct; Isotope dilution; Kidney; LC MS MS

Indexed keywords

RATTUS; SUIDAE;

DEOXYGUANOSINE; DNA; MYCOTOXIN; NUCLEOTIDE; OCHRATOXIN;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG EFFECT; FISCHER 344 RAT; ISOLATION AND PURIFICATION; KIDNEY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RAT;

ADMINISTRATION, ORAL; ANIMALS; CHROMATOGRAPHY, LIQUID; DEOXYGUANOSINE; DNA; KIDNEY; MALE; MASS SPECTROMETRY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MYCOTOXINS; NUCLEOTIDES; OCHRATOXINS; RATS; RATS, INBRED F344;

EID: 48649097150     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700276     Document Type: Article

References (56)

1. Weidenbörner, M., Encyclopedia of Food Mycotoxins, Springer-Verlag, Berlin 2001.
2. Hussein, H. S., Brasel, J. M., Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology 2001, 167, 101-134.
3. Pittet, A., Natural occurrence of mycotoxins in foods and feeds- an updated review. Rev. Méd. Vét. 1998, 6, 479-492.
4. Ceovic, S., Pleština, R., Miletic-Medved, M., Stavljenic, A. et al., Epidemiological aspects of Balkan endemic nephropathy in a typical focus in Yugoslavia, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I.N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, International Agency for Research on Cancer, Lyon, IARC Sci. Publ. 1991, 115, 5-10.
5. Radic, B., Fuchs, R., Peraica, M., Lucic, A., Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol. Lett. 1997, 91, 105-109.
6. Kuiper-Goodman, T., Risk assessment of ochratoxin A: An update. Food Addit. Contam. 1996, 13, 53-57.
7. World Health Organization, Safety evaluation of certain mycotoxins in food, prepared by the 56th meeting of the Joint FAO/WHO expert committee on food additives (JECFA), WHO Food Addit. Ser. 2001, 47, 281-415.
8. Bendele, A. M., Carlton, W. W., Krogh, P., Lillehoj, E. B., Ochratoxin A carcinogenesis in the (C57BL/6J X C3H)F1 mouse. J. Natl. Cancer Inst. 1985, 75, 733-742.
9. Boorman, G. A., McDonald, M. R., Imoto, S., Persing, R., Renal lesions induced by ochratoxin A exposure in the F344 rat. Toxicol. Pathol. 1992, 20, 236-245.
10. O'Brien, E., Dietrich, D. R., Ochratoxin A: The continuing enigma. Crit. Rev. Toxicol. 2005, 35, 33-60.
11. World Health Organization, Toxicological evaluation of certain food additives and contaminants, prepared by the 44th meeting of the Joint FAO/WHO expert committee on food additives (JECFA), WHO Food Addit. Ser. 1996, 35, 363-376.
12. European Food Safety Authority, Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to ochratoxin A in food, EFSA-Q-2005-154, EFSA J. 2006, 365, 1-56.
13. Kuiper-Goodman, T., Scott, P. M., Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 1989, 2, 179-248.
14. Malaveille, C., Brun, G., Bartsch, H., Structure-activity studies in E. coli strains on ochratoxin A (OTA) and its analogues implicate a genotoxic-free radical and a cytotoxic thiol derivative as reactive metabolites, Mutat. Res. 1994, 307, 141-147.
15. 3H]-label from low doses of radioactive ochratoxin A ingested by rats, and evidence for DNA single-strand breaks caused in liver and kidneys. Arch. Toxicol. 1986, 58, 219-224.
16. Hennig, A., Fink-Gremmels, J., Leistner, L., Mutagenicity and effects of ochratoxin A on the frequency of sister chromatid exchange after metabolic activation, in: Castegnaro, M., Plestina, R., Dirheimer, G., Chernozemsky, I. N., Bartsch, H. (Eds.), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, International Agency for Research on Cancer, Lyon, IARC Sci. Publ. 1991, 115, 255-260.
17. De Groene, E. M., Hassing, I. G., Blom, M. J., Seinen, W., et al., Development of human cytochrome P450-expressing cell lines: application in mutagenicity testing of ochratoxin A. Cancer Res. 1996, 56, 299-304.
18. Pfohl-Leszkowicz, A., Grosse, Y., Kane, A., Creppy, E. E., Dirheimer, G., Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A. Mutat. Res. 1993, 289, 265-273.
19. Grosse, Y., Baudrimont, I., Castegnaro, M., Betbeder, A.-M., et al., Formation of ochratoxin A metabolites and DNA-adducts in monkey kidney cells, Chem. Biol. Interact. 1995, 95, 175-187.
20. Gautier, J.-C., Richoz, J., Welti, D. H., Markovic, J., et al., Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes. Chem. Res. Toxicol. 2001, 14, 34-45.
21. Zepnik, H., Pähler, A., Schauer, U., Dekant, W., Ochratoxin A-induced tumor formation: Is there a role of reactive ochratoxin A metabolites? Toxicol. Sci. 2001, 59, 59-67.
22. Schlatter, C., Studer, R. J., Rasonyi, T., Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit. Contam. 1996, 13, 43-44.
23. Mally, A., Zepnik, H., Wanek, P., Eder, E., et al., Ochratoxin A: Lack of formation of covalent DNA adducts. Chem. Res. Toxicol. 2004, 17, 234-242.
24. Dai, J., Wright, M. W., Manderville, R. A., Ochratoxin A forms a carbon-bonded C8-deoxyguanosine nucleoside adduct: Implications for C8 reactivity by a phenolic radical. J. Am. Chem. Soc. 2003, 125, 3716-3717.
25. Faucet, V., Pfohl-Leszkowicz, A., Dai, J., Casteganro, M., Manderville, R. A., Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem. Res. Toxicol. 2004, 17, 1289-1296.
26. Beaucage, S. L., Iyer, R. P., Advances in the synthesis of oligonucleotides by the phosphoramidite approach. Tetrahedron 1992, 48, 2223-2311.
27. Rached, E., Hard, G. C., Blumbach, K., Weber, K., et al., Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/n rats. Toxciol. Sci. 2007, 97, 288-298.
28. National Toxicological Program, Toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303-47-9) in F344/N rats (gavage studies), Natl. Toxicol. Program Tech. Rep. Ser. 1989, 358, 1-142.
29. Mally, A., Volkel, W., Amberg, A., Kurz, M., et al., Functional, biochemical, and pathological effects of repeat oral administration of ochratoxin A to rats. Chem. Res. Toxicol. 2005, 18, 1242-1252.
30. Pfohl-Leszkowicz, A., Bartsch, H., Azemar, B., Mohr, U., et al., Mesna protects against nephrotoxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways. Facta Univ. Med. Biol. 2002, 9, 57-63.
31. Apruzzese, W. A., Vouros, P., Analysis of DNA adducts by capillary methods coupled to mass spectrometry: A perspective. J. Chromatogr. A 1998, 794, 97-108.
32. 6-etheno-2′-deoxyguanosine in human urine by column switching LC/API-MS/MS. Free Radic. Biol. Med. 2004, 36, 1383-1392.
33. Sulyok, M., Berthiller, F., Krska, R., Schuhmacher, R., Development and validation of a liquid chromatography/tandem mass spectrometric method for the determination of 39 mycotoxins in wheat and maize, Rapid Commun. Mass Spectrom. 2006, 20, 2649-2659.
34. Ventura, M., Guillen, D., Anaya, I., Broto-Puig, F., et al., Ultra-preformance liquid chormatography/tandem mass spectrometry for the simultaneous analysis of aflatoxins B1, G1, B2, G2 and ochratoxin A in beer. Rapid Commun. Mass Spectrom. 2006, 20, 3199-3204.
35. Mally, A., Dekant, W., DNA adduct formation by ochratoxin A: Review of the available evidence. Food Addit. Contam. 2005, 22, 65-74.
36. Manderville, R. A., A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduction. Chem. Res. Toxicol. 2005, 18, 1091-1097.
37. Pfohl-Leszkowicz, A., Castegnaro, M., Further arguments in favour of direct covalent binding of ochratoxin A (OTA) after metabolic biotransformation, Food Addit. Contam. 2005, 22, 75-87.
38. Turesky, R. J., Perspective: Ochratoxin A is not a genotoxic carcinogen, Chem. Res. Toxicol. 2005, 18, 1082-1090.
39. Gross-Steinmeyer, K., Weymann, J., Hege, H. G., Metzler, M., Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatcoytes. J. Agric. Food Chem. 2002, 50, 938-945.
40. Wehner, F. C., Thiel, P. G., van Rensburg, S. J., Demasius, I. P., Mutagenicity to Salmonella typhimurium of some Aspergillus and Penicillium mycotoxins. Mutat. Res. 1978, 58, 193-203.
41. Wurgler, F. E., Friederich, U., Schlatter, J., Lack of mutagenicity of ochratoxin A and B, citrinin, patulin, and cnestine in Salmonella typhimurium TA102. Mutat. Res. 1991, 261, 209-216.
42. Follmann, W., Lucas, S., Effects of the mycotoxin ochratoxin A in a bacterial and a mammalian in vitro mutagenicity test system. Arch. Toxicol. 2003, 77, 298-304.
43. Pfohl-Leskowicz, A., Grosse, Y., Castegnaro, M., Nicolov, I. G., et al., Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects. IARC Sci. Publ. 1993, 124, 141-148.
44. Arlt, V. M., Pfohl-Leskowicz, A., Cosyns, J., Schmeiser, H. H., Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat. Res. 2001, 494, 143-150.
45. Mally, A., Pepe, G., Ravoori, S., Fiore, M., et al., Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem. Res. Toxicol. 2005, 18, 1253-1261.
46. Marin-Kuan, M., Nestler, S., Verguet, C., Bezençon, C., et al., A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin A carcinogenicity in rat. Toxicol. Sci. 2006, 89, 120-134.
47. Cavin, C., Delatour, T., Marin-Kuan, M., Holzhäuser, D., et al., Reduction in antioxidant defences may contribute to ochratoxin A toxicity and carcinogenicity. Toxicol. Sci. 2006, 96, 30-39.
48. Stemmer, K., Ellinger-Ziegelbauer, H., Ahr, H.-J., Dietrich, D. R., Carcinogen-specific gene expression profiles in short-term treated Eker and wild-type rats indicative of pathways involved in renal tumorigenesis. Cancer Res. 2007, 67, 4052-4068.
49. Pfohl-Leszkowicz, A., Chakor, K., Creppy, E. E., Dirheimer, G., DNA adduct formation in maice treated with ochratoxin A. IARC Sci. Publ. 1991, 115, 245-253.
50. Kanisawa, M., in: Kurata, H., Ueno, Y. (Eds.), Toxigenic Fungi - Their Toxins and Health Hazards, Elsevier, Kodansha, Tokyo, Amsterdam 1984, pp. 245-254.
51. Gharbi, A., Trillon, O., Betbeder, A. M., Counrod, J., et al., Some effects of ochratoxin A, a mycotoxin contaminating feeds and food, on rat testis. Toxicology 1993, 83, 9-18.
52. 1 in vitro. Proc. Natl. Acad. Sci. USA 1977, 74, 1870-1874.
53. 1: Mechansitic studies, J. Am. Chem. Soc. 1994, 116, 1603-1609.
54. 6-etheno-2′- deoxyadenosine in DNA using on-line sample preparation by HPLC column switching coupled to ESI-MS/MS. J. Chromatogr. B 2006, 830, 255-261.
55. Choi, B. K., Hercules, D. M., Gusev, A. I., Effect of liquid chromatographic separation of complex matrices on liquid chromatography-tandem mass spectrometry signal suppression. J. Chromatogr. A 2001, 907, 337-342.
56. Delatour, T., Performance of quantitative analyses by liquid chromatography-electrospray ionisation tandem mass spectrometry: From external calibration to isotopomer-based exact matching. Anal. Bioanal. Chem. 2004, 380, 515-523.